Atlas Trials

A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate

Clinical trial NCT02706873 · COMPLETED

Trial details

NCT number
NCT02706873
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2016-02-23
Primary completion
2018-03-15
Enrollment
1002

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.